In vitro stimulation of terminally exhausted CD8+ TIL from non-small-cell lung cancer patients with IL-15 rescued lymphocyte responsiveness to PD-1 blockade and enhanced proliferation (42). This evidence concerns the gene CD8A and non-small cell lung carcinoma.